Eli Lilly & Co.’s antibody therapy was granted an emergency-use authorization by U.S. drug regulators for treating Covid-19, widening access to a treatment that early data suggest is effective in keeping people infected with the coronavirus out of the hospital.
The Food and Drug Administration authorized the experimental treatment, called bamlanivimab, for use against mild-to-moderate Covid-19 in adults, including those who are 65 and older, and pediatric patients, the agency said in a statement.
The clearance gives doctors an option for tackling the virus in high-risk patients before they’re sick enough to require hospitalization. Other treatments that received the regulatory go-ahead, such as convalescent plasma, a component collected from the blood of recovered Covid patients containing immune factors, and Gilead Sciences Inc.’s antiviral remdesivir, are intended for use in severely ill Covid-19 patients.
The U.S. government will pay Lilly $375 million for 300,000 vials of the antibody treatment. The initial agreement is for delivery over the first two months following a regulatory green light. The U.S. also has the option to purchase an additional 650,000 vials through next June for as much as $812.5 million.
Experimental antibody treatments could become a powerful component of the arsenal that doctors use to treat the coronavirus. Anthony Fauci, the top U.S. infectious-disease official, has referred to antibody-based medicines as a bridge to a vaccine. The class of treatments was thrust into the spotlight when President Donald Trump received an antibody cocktail made by Regeneron Pharmaceuticals Inc. after becoming infected with Covid-19.
What an AWESOME start to the week. And by awesome I mean absolutely, unequivocally the best possible start to a week we can have not just as a country, but as a goddamn planet. I feel like President Whitmore before he gives his speech in Independence Day where he unites not only the country, but the world:
We are fighting for our right to live. To exist. And should we win the day, the Fourth of July will no longer be known as an American holiday, but as the day the world declared in one voice: "We will not go quietly into the night!" We will not vanish without a fight! We're going to live on! We're going to survive! Today we celebrate our Independence Day!
Now obviously we have a LONG way to go before we drop that goddamn city wide spacecraft that's been hovering above us for the entirety of 2020, but we're almost there. Russell Casse is ALMOST about to fly his fighter jet into the spacecraft's primary weapon.
First, we had news that Pfizer had a breakthrough with a vaccine that worked with 90% or so efficacy. HUGE news that clem detailed here:
100 million vials of this vaccine are ready to rock apparently. That's just under 1/3 of the country. That's a HUGE number - especially when you don't have to worry about vaccinating the majority of the population quite yet. 10.5 million people have already contracted the virus, so you don't have to worry about them for now. That, and most people who are healthy and young you can put at the back of the line too. So once we figure out the logistics of how to vaccinate the immunocompromised and elderly, we can finally start to get back to living a normal life, and we'll get to that method in a moment.
And speaking of logistics, I'm sure that's going to be a complete and total bitch. The army (who is the distributor) and refrigeration manufacturers have their work cut out for them in the coming months. Apparently the vaccine needs to be stored at -94 degrees, so I'm sure this is going to be an incredibly tedious process in the coming months. Take it from me - I was a freight broker in my entire life. Figuring out how to safely transport anything at that temperature is going to be a pain in the goddamn ass - but I have no doubts our government will figure it out with the different industries that are in on the production and distribution of this thing.
BUT - and this gets us back to the original thesis of the blog - apparently we now have a breakthrough on a "bridge" therapy to the vaccine, Eli Lilly and Co's antibody therapy. This therapy has proven affective in keeping people currently infected with covid out of the hospital and that has been a major reason why this disease has sucked so much construction worker swamp ass, to put it in Eddie's words - because it's overflowed and overrun hospitals. If we can keep people out of the hospital while we work to get this vaccine injected into directly into the veins of 100MM Americans and continuing to push the death rate down, I think we will MAYBE, just MAYBE watching these dude's dominate this year in person:
Nevertheless, awesome news all around on the corona front this week. We're starting to see the light at the end of the tunnel.
PS - And now we survive in Verdansk, as well.